Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 6/20 | 0.67 |
| ▸ | MGLL | Q99685 | 3/20 | 0.59 |
| ▸ | THRA | P10827 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.53 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9304902 | 1.00 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBCNR2 | |
| SCHEMBL9565566 | 1.00 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBCNR2 | |
| SCHEMBL24950547 | 1.00 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBCNR2 | |
| SCHEMBL7335792 | 0.98 | SMPD1 (0.64) | SMPD1MGLLTHRATHRBCNR2 | |
| SCHEMBL9307263 | 0.94 | SMPD1 (0.76) | SMPD1MGLLTHRATHRBCNR2 | |
| SCHEMBL29171402 | 0.94 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBPLA2G4B | |
| SCHEMBL29171445 | 0.94 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBPLA2G4B | |
| SCHEMBL14930509 | 0.94 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBPLA2G4B | |
| SCHEMBL9307505 | 0.94 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBPLA2G4B | |
| SCHEMBL29171438 | 0.94 | SMPD1 (0.67) | SMPD1MGLLTHRATHRBPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200290980-A1 | POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2020-09-17 | — | — | US | disclosed |
| CN-109790128-A | Multichain ligand and the mixing nano particle being made from it | 罗地亚经营管理公司 | 2019-05-21 | — | — | CN | disclosed |
| EP-3430001-A1 | POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM | Rhodia Operations (FR) | 2019-01-23 | — | — | EP | disclosed |
| WO-2017161293-A9 | POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM | RHODIA OPERATIONS (FR) | 2019-01-10 | — | — | WO | disclosed |
| WO-2017161293-A1 | POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM | RHODIA OPERATIONS (FR) | 2017-09-21 | — | — | WO | disclosed |
| CN-103980123-B | Protocatechuic acid-based liquid crystal compound with high fullerene content and preparation method thereof | SOOCHOW UNIVERSITY (CN) | 2015-11-25 | — | — | CN | disclosed |
| CN-104447592-A | Cyanuric acid derivative, disc-like liquid crystal material and melamine detection method | UNIV SOUTHEAST | 2015-03-25 | — | — | CN | disclosed |
| CN-103980123-A | Protocatechuic acid-based liquid crystal compound with high fullerene content and preparation method thereof | UNIV SOOCHOW | 2014-08-13 | — | — | CN | disclosed |
| US-20110009584-A1 | Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-01-13 | — | — | US | disclosed |
| EP-2234991-A1 | ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY | Georgia Tech Research Corporation (US) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009080797-A1 | ROMP-POLYMERIZABLE ELECTRON TRANSPORT MATERIALS BASED ON A BIS-OXADIAZOLE MOIETY | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200290980-A1 | POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM | PICALM, CD63, EPCAM | SMPD1 4768/4885MGLL 2813/4885THRA 3530/4885 |
| US-20110009584-A1 | Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety | SLCO1B3, SLCO4C1, SLCO2B1 | SMPD1 4884/4885MGLL 4494/4885THRA 3279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.